biotech news today glp-1 What's next for innovation: A primer on the race reshaping pharma and chronic disease care The current range of weight-loss

RM-131 (100 g/day, subcutaneous) accelerated gastric emptying in patients with type 1 or 2 diabetes who had upper gastrointestinal symptoms

Its administration can lead to noteworthy cardiovascular side effects, such as elevated heart rate and blood pressure, and has been linked to an augmented risk of heart attack, stroke, and withdrawal symptoms upon abrupt cessation

10.1016/j.ijbiomac.2019.09.172 36

Check out reviews from our favorite food critics

doi:10.3390/nu9101053 111

These medications work by slowing digestion, supporting insulin regulation, and reducing appetite, which means that how and what you eat can play a major role in your results, your comfort, and your long-term success